Intriguingly, however, transgenic expression of CCL2 on the non-obese diabetic mouse background, a model of autoimmune-mediated islet destruction, delays diabetes development despite increased immune cell accumulation in islets [19]. The gene discussed is CCL2; the disease is diabetes mellitus.